We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDF icon
6326
Cardiff Oncology
CRDF
$66.2M
$1K ﹤0.01%
59
-25
-30% -$616
CZWI icon
6327
Citizens Community Bancorp
CZWI
$211M
$1K ﹤0.01%
54
+53
+5,300% +$730
DFND
6328
DELISTED
Siren DIVCON Dividend Defender ETF
DFND
$1K ﹤0.01%
+53
New +$1.47K
KUST
6329
Kustom Entertainment Inc
KUST
$740K
0
DUG icon
6330
ProShares UltraShort Energy
DUG
$21M
$1K ﹤0.01%
1
-91
-99% -$69.6K
ESEA icon
6331
Euroseas
ESEA
$560M
$1K ﹤0.01%
89
-4
-4% -$49
FDMO icon
6332
Fidelity Momentum Factor ETF
FDMO
$916M
$1K ﹤0.01%
+46
New +$1.49K
FDRR icon
6333
Fidelity Dividend ETF for Rising Rates
FDRR
$735M
$1K ﹤0.01%
47
-149
-76% -$4.63K
FTFT icon
6334
Future FinTech Group
FTFT
$1.72M
$1K ﹤0.01%
+1
New +$2.46K
GLBZ
6335
DELISTED
Glen Burnie Bancorp
GLBZ
$1K ﹤0.01%
68
INUV icon
6336
Inuvo
INUV
$15.9M
$1K ﹤0.01%
100
-16,730
-99% -$149K
LPTH icon
6337
Lightpath Technologies
LPTH
$648M
$1K ﹤0.01%
+516
New +$1.18K
LTRX icon
6338
Lantronix
LTRX
$239M
$1K ﹤0.01%
789
+703
+817% +$1.56K
MRKR icon
6339
Marker Therapeutics
MRKR
$18.7M
$1K ﹤0.01%
26
+25
+2,500% +$883
MTEX icon
6340
Mannatech
MTEX
$9.42M
$1K ﹤0.01%
61
NNDM
6341
Nano Dimension
NNDM
$324M
$1K ﹤0.01%
50
NSPR icon
6342
InspireMD
NSPR
$31.5M
$1K ﹤0.01%
+2
New +$6.89K
OESX icon
6343
Orion Energy Systems
OESX
$40.3M
$1K ﹤0.01%
+101
New +$852
OPTT icon
6344
Ocean Power Technologies
OPTT
$43.5M
$1K ﹤0.01%
77
+68
+756% +$1.54K
PANL icon
6345
Pangaea Logistics
PANL
$493M
$1K ﹤0.01%
500
-5,400
-92% -$15.2K
PNBK icon
6346
Patriot National Bancorp
PNBK
$128M
$1K ﹤0.01%
51
AGPU
6347
Axe Compute Inc
AGPU
$96.8M
0
PSTV icon
6348
Plus Therapeutics
PSTV
$25.1M
0
REK icon
6349
ProShares Short Real Estate
REK
$11.7M
$1K ﹤0.01%
37
-10
-21% -$338
RGLS
6350
DELISTED
Regulus Therapeutics
RGLS
$1K ﹤0.01%
15
-9
-38% -$1.2K

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.